Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

175.34
Delayed Data
As of Sep 20
 -0.14 / -0.08%
Today’s Change
174.41
Today|||52-Week Range
242.97
-26.22%
Year-to-Date

Today’s Trading

Previous close175.66
Today’s open176.00
Day’s range174.41 - 179.49
Volume565,315
Average volume (3 months)565,981
Market cap$23.1B
Data as of 3:59pm ET, 09/20/2023

Growth & Valuation

Earnings growth (last year)-29.11%
Earnings growth (this year)+34.66%
Earnings growth (next 5 years)+1.50%
Revenue growth (last year)+22.88%
P/E ratioNM
Price/Sales27.88
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Therapeutics...+0.09+0.08%
ESAIYEisai Co Ltd-0.13-0.86%
----
INCYIncyte Corp-0.23-0.38%
Data as of 4:00pm ET, 09/20/2023

Financials

Next reporting dateOctober 26, 2023
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$1.0B
Annual profit (last year)-$1.1B
Net profit margin-109.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts